Erasca (ERAS) Recoups 16.9% Gain on Cancer Treatment Optimism
Summary
Erasca snapped a four-day losing streak on Thursday, soaring 16.90 percent to close at $10.65 apiece, as investors resorted to bargain-hunting following a steep...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.